SPA Pricing Education, Analytics & Decision Making Tools Webinar Series

Tag: Price Negotiations

3 Ways You Can Conquer Customer Price Fixation | Jeff Shore

3 Ways You Can Conquer Customer Price Fixation | Jeff Shore

Salesperson: “Welcome, and thanks for stopping by.” Customer: “What’s your price?” Salesperson: “Well, we will certainly get to that. How’s your day going?” Customer: “What’s your price?” Salesperson: “Okay, I’ll be happy to answer that but can I ask you a few questions first?” Customer: “What’s your price?” Salesperson: “Well, we actually have several options […]

Lilly offers up drug pricing details amid ongoing scrutiny of industry | BioPharma Dive

Lilly offers up drug pricing details amid ongoing scrutiny of industry | BioPharma Dive

Dive Brief: Indianapolis drugmaker Eli Lilly on Monday disclosed more details about the effects of rebates and discounts on pricing, in what has become an increasingly common move among drugmakers to address concerns over the high costs of prescription drugs. In its 2016 Lilly Integrated Summary Report, the company said average net price increases for its […]

‘Full Measure’: Drug prices | WJLA

‘Full Measure’: Drug prices | WJLA

WASHINGTON (Sinclair Broadcast Group) – The Skenderian family has been in the pharmacy business for about 80 years. Today, Joe and his brothers operate Skenderian Apothecary in Cambridge, Massachusetts. Skenderian: “We have the same pharmacists that have been working here, some of us for 20 or 30 years and, of course, some of the patients […]

Amgen dodges drug pricing inquiry | The Acorn

Amgen dodges drug pricing inquiry | The Acorn

A shareholder group has been turned away in its attempt to force Amgen to reveal how it sets the prices of its top-selling prescription drugs. The shareholder group, Mercy Investment Services, told Amgen in a letter that its members are worried about consumer outrage over high pharmaceutical prices and by comments made by President Trump […]

Did Emflaza’s DMD approval expose cracks at the FDA? Lawmakers want to know | FiercePharma

Did Emflaza’s DMD approval expose cracks at the FDA? Lawmakers want to know | FiercePharma

After lambasting Marathon Pharma for its pricing strategy on a decades-old med recently approved to treat Duchenne muscular dystrophy, Sen. Bernie Sanders and Rep. Elijah Cummings are turning their fire on the FDA. The congressmen wrote FDA Acting Commissioner Stephen Ostroff to pose some “serious questions” about the agency’s review and approval for Emflaza. They […]

Drug pricing: caught between ethics and politics | Financier Worldwide

Drug pricing: caught between ethics and politics | Financier Worldwide

Drug pricing has become a topic of much heated debate, both on the political stage and among drug companies, patients and payors. Many of us are either directly or indirectly (through friends and family) affected by what seem to be ever-rising drugs prices, insurance premiums or co-payments. Society, in the form of public payors or […]

Biogen’s Spinraza sparks pricing concerns as Trump renews attack on pharma | FiercePharma

Biogen’s Spinraza sparks pricing concerns as Trump renews attack on pharma | FiercePharma

Is Spinraza the next Sovaldi? That’s the question on the minds of health insurers, analysts and investors as Biogen launches Spinraza (nusinersen), its highly anticipated spinal muscular atrophy (SMA) drug. The drug will cost $125,000 per injection, amounting to $750,000 for the first year and $375,000 after that. That’s why Spinraza is bringing to mind […]

Vaccine Makers Ranked on Pricing and Research | The New York Times

Vaccine Makers Ranked on Pricing and Research | The New York Times

The pharmaceutical companies GlaxoSmithKline and Sanofi sell many doses of vaccines at high prices and do a lot of research with the profits, while the Serum Institute of India makes more doses than any other manufacturer and sells them at low prices, according to the first Access to Vaccines Index, which was released last week. […]

SPA Featured in The Distributor Channel article “Every Silver Cloud has a Dark Lining: Things to Consider in a Growth Economy” | Strategic Pricing Associates

SPA Featured in The Distributor Channel article “Every Silver Cloud has a Dark Lining: Things to Consider in a Growth Economy” | Strategic Pricing Associates

“I believe a solid pricing process is an essential part of any strategic initiative.  There’s three big reasons why:” Pricing Process drives bottom line results.  The typical distributor using David Bauders’ Strategic Pricing Associates improves gross margin by two points.  In some industries, this nearly doubles the bottom line results.  For most distributors the gain […]

Express Scripts responds to Gilead drug pricing comments | Business Insider

Express Scripts responds to Gilead drug pricing comments | Business Insider

As scrutiny of high drug prices in the US intensifies, so has the finger pointing about who is to blame. This week, that came in the form of an interview in which an executive at Gilead blamed high prices on pharmacy benefit managers, the companies that help insurance plans determine what drugs they’ll cover and how much they’ll pay. […]